These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

367 related items for PubMed ID: 26853494

  • 21. Clinicopathologic and genetic characteristics of young patients with pleural diffuse malignant mesothelioma.
    Vivero M, Bueno R, Chirieac LR.
    Mod Pathol; 2018 Jan; 31(1):122-131. PubMed ID: 28884745
    [Abstract] [Full Text] [Related]

  • 22. DNA copy number changes in familial malignant mesothelioma.
    Ascoli V, Aalto Y, Carnovale-Scalzo C, Nardi F, Falzetti D, Mecucci C, Knuutila S.
    Cancer Genet Cytogenet; 2001 May; 127(1):80-2. PubMed ID: 11408072
    [Abstract] [Full Text] [Related]

  • 23. BAP1 protein is a progression factor in malignant pleural mesothelioma.
    Arzt L, Quehenberger F, Halbwedl I, Mairinger T, Popper HH.
    Pathol Oncol Res; 2014 Jan; 20(1):145-51. PubMed ID: 23963927
    [Abstract] [Full Text] [Related]

  • 24. A cluster of familial malignant mesothelioma with del(9p) as the sole chromosomal anomaly.
    Musti M, Cavone D, Aalto Y, Scattone A, Serio G, Knuutila S.
    Cancer Genet Cytogenet; 2002 Oct 01; 138(1):73-6. PubMed ID: 12419589
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Characterization of DNA hypermethylation in two cases of peritoneal mesothelioma.
    Hama R, Watanabe Y, Shinada K, Yamada Y, Ogata Y, Yoshida Y, Tamura T, Hiraishi T, Oikawa R, Sakurai J, Maehata T, Koizumi H, Itoh F.
    Tumour Biol; 2012 Dec 01; 33(6):2031-40. PubMed ID: 22836805
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Differential mutation profiles and similar intronic TP53 polymorphisms in asbestos-related lung cancer and pleural mesothelioma.
    Andujar P, Pairon JC, Renier A, Descatha A, Hysi I, Abd-Alsamad I, Billon-Galland MA, Blons H, Clin B, Danel C, Debrosse D, Galateau-Sallé F, Housset B, Laurent-Puig P, Le Pimpec-Barthes F, Letourneux M, Monnet I, Régnard JF, Validire P, Zucman-Rossi J, Jaurand MC, Jean D.
    Mutagenesis; 2013 May 01; 28(3):323-31. PubMed ID: 23435014
    [Abstract] [Full Text] [Related]

  • 29. Comparison of genomic abnormality in malignant mesothelioma by the site of origin.
    Takeda M, Kasai T, Enomoto Y, Takano M, Morita K, Nakai T, Iizuka N, Maruyama H, Ohbayashi C.
    J Clin Pathol; 2014 Dec 01; 67(12):1038-43. PubMed ID: 25217709
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Risk of second primary cancers after malignant mesothelioma and vice versa.
    Chen T, Kharazmi E, Lou J, Zhang X, Sundquist K, Hemminki K.
    Cancer Lett; 2016 Aug 28; 379(1):94-9. PubMed ID: 27260871
    [Abstract] [Full Text] [Related]

  • 33. Asbestos, chromosomal deletions, and tumor suppressor gene alterations in human malignant mesothelioma.
    Murthy SS, Testa JR.
    J Cell Physiol; 1999 Aug 28; 180(2):150-7. PubMed ID: 10395284
    [Abstract] [Full Text] [Related]

  • 34. Evaluation of prognostic histological parameters proposed for pleural mesothelioma in diffuse malignant peritoneal mesothelioma. A short report.
    Pezzuto F, Vimercati L, Fortarezza F, Marzullo A, Pennella A, Cavone D, Punzi A, Caporusso C, d'Amati A, Lettini T, Serio G.
    Diagn Pathol; 2021 Jul 22; 16(1):64. PubMed ID: 34294087
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. The prognostic significance of BAP1, NF2, and CDKN2A in malignant peritoneal mesothelioma.
    Singhi AD, Krasinskas AM, Choudry HA, Bartlett DL, Pingpank JF, Zeh HJ, Luvison A, Fuhrer K, Bahary N, Seethala RR, Dacic S.
    Mod Pathol; 2016 Jan 22; 29(1):14-24. PubMed ID: 26493618
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Whole-exome sequencing reveals frequent genetic alterations in BAP1, NF2, CDKN2A, and CUL1 in malignant pleural mesothelioma.
    Guo G, Chmielecki J, Goparaju C, Heguy A, Dolgalev I, Carbone M, Seepo S, Meyerson M, Pass HI.
    Cancer Res; 2015 Jan 15; 75(2):264-9. PubMed ID: 25488749
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.